Beyond Air, Inc. (XAIR) Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors
Go back to Beyond Air, Inc. (XAIR) Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors| (NASDAQ: XAIR) | Delayed: 3.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.53 | 52 Week High | $ | |||
| Open | $3.53 | 52 Week Low | $ | |||
| Day High | $3.53 | P/E | N/A | |||
| Day Low | $3.53 | EPS | $ | |||
| Volume | 8,585 | |||||

